Robert Burns
Stock Analyst at HC Wainwright & Co.
(3.59)
# 853
Out of 5,143 analysts
479
Total ratings
43.48%
Success rate
7.98%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORIC ORIC Pharmaceuticals | Maintains: Buy | $23 → $25 | $13.65 | +83.15% | 27 | Feb 24, 2026 | |
| KPTI Karyopharm Therapeutics | Reiterates: Buy | $15 | $10.15 | +47.78% | 4 | Feb 18, 2026 | |
| EXEL Exelixis | Maintains: Buy | $52 → $54 | $45.10 | +19.73% | 15 | Feb 12, 2026 | |
| HURA TuHURA Biosciences | Reiterates: Buy | $10 | $1.40 | +614.29% | 5 | Feb 3, 2026 | |
| CATX Perspective Therapeutics | Maintains: Buy | $10 → $12 | $5.47 | +119.38% | 6 | Jan 30, 2026 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $31 → $32 | $15.86 | +101.77% | 21 | Jan 29, 2026 | |
| CRDF Cardiff Oncology | Reiterates: Buy | $10 | $1.79 | +460.22% | 4 | Jan 28, 2026 | |
| MOLN Molecular Partners AG | Initiates: Buy | $13 | $5.11 | +154.40% | 2 | Jan 27, 2026 | |
| ACET Adicet Bio | Maintains: Buy | $9 → $50 | $7.34 | +581.20% | 3 | Jan 21, 2026 | |
| TLX Telix Pharmaceuticals | Reiterates: Buy | $20 | $6.76 | +195.86% | 4 | Jan 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $17 | $5.66 | +200.35% | 18 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $13.97 | +93.27% | 4 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $52 | $39.65 | +31.15% | 16 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $8.84 | +35.75% | 10 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $32 | $24.01 | +33.28% | 23 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $136 → $140 | $110.42 | +26.79% | 46 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $104.82 | -30.36% | 21 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $9 | $1.98 | +355.70% | 15 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $2 | $1.88 | +6.38% | 22 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.63 | +207.69% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $8.35 | +43.71% | 20 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $7 | $5.04 | +38.89% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $4.29 | +63.36% | 22 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.91 | +71.82% | 17 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $10.34 | +161.12% | 1 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $2.63 | +1,192.78% | 4 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $9.26 | +51.19% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $17.23 | +132.15% | 5 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $42 | $23.43 | +79.26% | 11 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $2.59 | +286.10% | 14 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $10.41 | +24.94% | 8 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $28.73 | +67.07% | 5 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $12.91 | +0.70% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.09 | +358.72% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $2.46 | +225.87% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.71 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $20.49 | +876.09% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $0.79 | +30,279.75% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.47 | +31,917.08% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $5.68 | +93.66% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $2.16 | +2,083,233.33% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.86 | +598.92% | 1 | Jan 7, 2021 |
ORIC Pharmaceuticals
Feb 24, 2026
Maintains: Buy
Price Target: $23 → $25
Current: $13.65
Upside: +83.15%
Karyopharm Therapeutics
Feb 18, 2026
Reiterates: Buy
Price Target: $15
Current: $10.15
Upside: +47.78%
Exelixis
Feb 12, 2026
Maintains: Buy
Price Target: $52 → $54
Current: $45.10
Upside: +19.73%
TuHURA Biosciences
Feb 3, 2026
Reiterates: Buy
Price Target: $10
Current: $1.40
Upside: +614.29%
Perspective Therapeutics
Jan 30, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $5.47
Upside: +119.38%
Nurix Therapeutics
Jan 29, 2026
Maintains: Buy
Price Target: $31 → $32
Current: $15.86
Upside: +101.77%
Cardiff Oncology
Jan 28, 2026
Reiterates: Buy
Price Target: $10
Current: $1.79
Upside: +460.22%
Molecular Partners AG
Jan 27, 2026
Initiates: Buy
Price Target: $13
Current: $5.11
Upside: +154.40%
Adicet Bio
Jan 21, 2026
Maintains: Buy
Price Target: $9 → $50
Current: $7.34
Upside: +581.20%
Telix Pharmaceuticals
Jan 21, 2026
Reiterates: Buy
Price Target: $20
Current: $6.76
Upside: +195.86%
Jan 12, 2026
Maintains: Buy
Price Target: $18 → $17
Current: $5.66
Upside: +200.35%
Jan 8, 2026
Maintains: Buy
Price Target: $26 → $27
Current: $13.97
Upside: +93.27%
Jan 6, 2026
Maintains: Buy
Price Target: $50 → $52
Current: $39.65
Upside: +31.15%
Dec 9, 2025
Maintains: Buy
Price Target: $8 → $12
Current: $8.84
Upside: +35.75%
Nov 18, 2025
Maintains: Buy
Price Target: $26 → $32
Current: $24.01
Upside: +33.28%
Nov 10, 2025
Maintains: Buy
Price Target: $136 → $140
Current: $110.42
Upside: +26.79%
Nov 6, 2025
Maintains: Buy
Price Target: $72 → $73
Current: $104.82
Upside: -30.36%
Nov 5, 2025
Maintains: Buy
Price Target: $3 → $9
Current: $1.98
Upside: +355.70%
Nov 3, 2025
Reiterates: Neutral
Price Target: $2
Current: $1.88
Upside: +6.38%
Oct 31, 2025
Upgrades: Buy
Price Target: $5
Current: $1.63
Upside: +207.69%
Oct 27, 2025
Upgrades: Buy
Price Target: $12
Current: $8.35
Upside: +43.71%
Oct 20, 2025
Assumes: Buy
Price Target: $7
Current: $5.04
Upside: +38.89%
Oct 16, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $4.29
Upside: +63.36%
Sep 23, 2025
Reiterates: Buy
Price Target: $5
Current: $2.91
Upside: +71.82%
Sep 15, 2025
Initiates: Buy
Price Target: $27
Current: $10.34
Upside: +161.12%
Aug 26, 2025
Reiterates: Buy
Price Target: $34
Current: $2.63
Upside: +1,192.78%
Aug 26, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $9.26
Upside: +51.19%
Aug 22, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $17.23
Upside: +132.15%
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $23.43
Upside: +79.26%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.59
Upside: +286.10%
Jul 17, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $10.41
Upside: +24.94%
Jul 2, 2025
Maintains: Buy
Price Target: $40 → $48
Current: $28.73
Upside: +67.07%
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $12.91
Upside: +0.70%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.09
Upside: +358.72%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $2.46
Upside: +225.87%
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.71
Upside: -
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $20.49
Upside: +876.09%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $0.79
Upside: +30,279.75%
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $0.47
Upside: +31,917.08%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $5.68
Upside: +93.66%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $2.16
Upside: +2,083,233.33%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.86
Upside: +598.92%